No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Mikhail Kosiborod, MD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Akshay S. Desai, MD
Promising results for self-expanding TAVR device in trial with mostly women
Hadley Wilson, MD
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Marc Bonaca, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.